oncolytic recombinant vesicular stomatitis virus vaccines (Vyriad)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameoncolytic recombinant vesicular stomatitis virus vaccines (Vyriad)

Drug Alias Nameoncolytic recombinant vesicular stomatitis virus vaccines (Profectus/Vyriad)rVSV vaccines (Profectus/Vyriad)

ClassificationVaccines > Application > Therapeutic vaccineBiologics > Oncolytic virusVaccines > Development/production technology > Recombinant vector vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVyriad +[2]

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A